Adaptive Biotechnologies (ADPT) Other Accumulated Expenses (2018 - 2025)

Adaptive Biotechnologies has disclosed Other Accumulated Expenses across 8 years of filings, most recently posting $826000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses changed 0.48% year-over-year to $826000.0; the TTM figure through Dec 2025 stood at $826000.0 (changed 0.48% YoY), while the FY2025 annual figure was $826000.0, changed 0.48% from the prior year.
• Other Accumulated Expenses came in at $826000.0 for Q4 2025 at Adaptive Biotechnologies, roughly flat from $830000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.7 million in Q4 2022 to a low of $763000.0 in Q4 2023.
• Average Other Accumulated Expenses over 5 years is $1.0 million, with a median of $830000.0 recorded in 2024.
• Year-over-year, Other Accumulated Expenses jumped 58.52% in 2022 and slumped 53.9% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $1.0 million in 2021, then jumped by 58.52% to $1.7 million in 2022, then tumbled by 53.9% to $763000.0 in 2023, then increased by 8.78% to $830000.0 in 2024, then retreated by 0.48% to $826000.0 in 2025.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $826000.0 in Q4 2025, $830000.0 in Q4 2024, and $763000.0 in Q4 2023.